As July concludes, the landscape of hematologic oncology continues to evolve, with notable progress in multiple myeloma, ...

Every week, the TDN posts a roundup of the relevant Horseracing Integrity and Safety Act (HISA) related rulings from around the country. The following rulings were reported on HISA's “rulings” portal ...

Paris: Sanofi has announced that the European Commission has approved Sarclisa in combination with bortezomib, lenalidomide, ...

Maybe you've heard of "cortisol face," or "cortisol belly" or read that yoga and meditation can help lower your cortisol levels, but what does that really mean? Cortisol is a hormone made by ...

Mumbai Monsoon May Trigger Brain-Affecting Tapeworm Infections: Neurocysticercosis is a serious brain infection caused by the ...

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing ...

London: GSK plc has received approval for Blenrep in the European Union (EU) for the treatment of adults with relapsed or ...

European Union approves GSK’s Blenrep combinations to treat relapsed/refractory multiple myeloma: London, UK Saturday, July 26, 2025, 11:00 Hrs [IST] GSK plc announced the appro ...

The European Commission (EC) has granted approval to Sanofi's Sarclisa in combination with a regimen of VRd for multiple myeloma.

Patients have been asking me about a recently published article that suggests a "'potential cure"' for myeloma is at hand.

The combinations are also approved for relapsed or refractory multiple myeloma in Japan, the UK and other markets including ...

Novel drug regimens, autologous stem cell transplant (ASCT), and modern supportive care are prolonging remission, improving ...